Early Covid-19 Research Isn’t As Inclusive As It Should Be

Experts agree that people of color must be adequately represented in coronavirus vaccine and drug trials. It’s unclear whether that’s happening.

A man stands outside Moderna headquarters in Cambridge, Massachusetts on May 18, 2020. The New England Journal of Medicine recently published the phase 1 results of Moderna’s promising mRNA vaccine. Photo: Joseph Prezioso/AFP/Getty Images

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store